Respiratory Syncytial Virus (RSV) Burden in Infants in the Kingdom of Saudi Arabia and the Impact of All-Infant RSV Protection: A Modeling Study.

Adel AlharbiAbdullah YousefAmal ZubaniMohammad AlzahraniMohammad Al-HindiSaleh AlharbiTurki AlahmadiHana AlabdulkarimPaulina KazmierskaMatthieu Beuvelet

Published in: Advances in therapy (2024)

Compared with current SoP, an nirsevimab immunoprophylaxis strategy in the KSA for all infants during their first RSV season was estimated to dramatically decrease healthcare resource use, and economic burden associated with RSV.

Keyphrases

respiratory syncytial virus
saudi arabia
healthcare
respiratory tract
risk factors